Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Packer, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Packer, R. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Childhood Brain Tumors: Accomplishments and Ongoing Challenges

Roger J. Packer, MD

Center of Excellence for Neuroscience and Behavioral Medicine, Division of Child Neurology, Children's National Medical Center, Washington, DC, rpacker{at}cnmc.org

The management of childhood brain tumors, which consist of many different histological subtypes, continues to be a challenge. Outcome, measured not only by survival rates but also by the effects of disease and therapy on quality of life, has improved over the past two decades for some tumor types, most notably medulloblastomas. For others, however, there has been little progress, and quality of life for long-term survivors remains suboptimal. Because of advances in our understanding of the biology underlying childhood brain tumors, treatments may change dramatically in the years ahead. Accordingly, survival rates may improve and long-term sequelae lessen.

Key Words: brain tumor • chemotherapy • medulloblastoma • glioma • ependymoma

References

  • Pollack IF, Finkelstein SD, Woods J., et al. Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med. 2002;346:420-427.[Abstract/Free Full Text]
  • Packer RJ, Cogen P., Vézina G., Rorke LB Medulloblastoma: clinical and biologic aspects. Neuro Oncol. 1999;1:232-250.[Abstract]
  • Albright AL, Sposto R., Holmes E., et al. Correlation of neurosurgical subspecialization with outcomes in children with malignant brain tumors. Neurosurgery. 2000;47:879-887.[Web of Science][Medline] [Order article via Infotrieve]
  • Robertson PL, Muraszko KM, Holmes EJ, et al. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group. J Neurosurg. 2006;105(S6 Pediatrics):444-451.[Web of Science][Medline] [Order article via Infotrieve]
  • Packer RJ, Gajjar A., Vézina G., et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24:4202-4208.[Abstract/Free Full Text]
  • Taylor RE, Bailey CC, Robinson K., et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. J Clin Oncol. 2003;21:1582-1591.
  • Gajjar A., Chintagumpala M., Ashley D., et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet. 2006;7:813-820.[CrossRef][Web of Science]
  • Kuhl J., Muller HL, Berthold F., et al. Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT'88/'89. Klin Padiatr. 1998;210:227-233.[Web of Science][Medline] [Order article via Infotrieve]
  • Read TA, Hegedus B., Wechsler-Reya R., Gutmann DH The neurobiology of neurooncology. Ann Neurol. 2006;6:3-11.
  • Raffel C., Jenkins RB, Frederick L., et al. Sporadic medulloblastomas contain PTCH mutation. Cancer Res. 1997;57: 842-845.[Abstract/Free Full Text]
  • MacDonald TJ, Brown KM, LaFleur B., et al. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet. 2001;29:143-152.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ris MD, Packer R., Goldwein J., et al. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study. J Clin Oncol. 2001;19:3470-3476.[Abstract/Free Full Text]
  • Mulhern RK, Kepner JL, Thomas PR, et al. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. J Clin Oncol. 1998;16:1723-1728.[Abstract]
  • Gurney JG, Kadan-Lottick NS, Packer RJ, et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer. 2003;47:663-673.
  • Packer RJ, Gurney JG, Punyko JA, et al. Longterm neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: Childhood Cancer Survivor Study. J Clin Oncol. 2003;21:3255-3261.[Abstract/Free Full Text]
  • Neglia JP, Robison LL, Stovall M., et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2006;98:1528-1537.[Abstract/Free Full Text]
  • Eberhart CG, Kratz J., Wang Y., et al. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia. J Neuropathol Exp Neurol. 2004;63:4441-4449.
  • Ellison DW, Onilude OE, Lindsey JC, et al. beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour committee. J Clin Oncol. 2005;23:7951-7957.[Abstract/Free Full Text]
  • Grotzer MA, Hogarty MD, Janss AJ, et al. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma. Clin Cancer Res. 2001;7:2425-2433.[Abstract/Free Full Text]
  • Gilbertson S., Wickramasinghe C., Hernan R., et al. Clinical and molecular stratification of disease risk in medulloblastoma. Br J Cancer. 2001;85:705-712.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Grotzer MA, Janss AJ, Fung K., et al. TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J Clin Oncol. 2000;18:1027-1035.[Abstract/Free Full Text]
  • Pomeroy S., Tamayo P., Gaasenbeek M., et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 2002;415:436-442.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Gajjar A., Hernan R., Kocak M., et al. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. J Clin Oncol. 2004;15;22:984-993.
  • Ray A., Ho M., Ma J., et al. A clinicobiological model predicting survival in medulloblastoma. Clin Cancer Res. 2004;10:7613-7620.[Abstract/Free Full Text]
  • Rorke LB, Packer RJ, Biegel JA Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg. 1996;85:56-65.[Web of Science][Medline] [Order article via Infotrieve]
  • Packer RJ, Biegel JA, Blaney S., et al. Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop. J Pediatr Hematol Oncol. 2002;24:337-342.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med. 1993;328:1725-1731.[Abstract/Free Full Text]
  • Rutkowski S., Bode U., Deinlein F., et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med. 2005;352:978-986.[Abstract/Free Full Text]
  • Geyer JR, Sposto R., Jennings M., et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol. 2005;23:7621-7631.[Abstract/Free Full Text]
  • Central Brain Tumor Registry of the United States. Statistical report: primary brain tumors in the United States, 1995-1999. Published by the Central Brain Tumor Registry of the United States; 2005.
  • Pollack IF The role of surgery in pediatric gliomas. J Neurooncol. 1999;42:271-288.[CrossRef][Medline] [Order article via Infotrieve]
  • Wisoff JH, Boyett JM, Berger MS, et al. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945. J Neurosurg. 1998;89:52-59.[Web of Science][Medline] [Order article via Infotrieve]
  • Packer RJ, Ata J., Allen J., et al. Treatment utilizing carboplatin and vincristine for children with newly-diagnosed progressive low-grade gliomas. J Neurosurg. 1997;56:747-754.
  • Sposto R., Ertel IJ, Jenkin RD, et al. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. J Neurooncol. 1989;7:165-177.[CrossRef][Medline] [Order article via Infotrieve]
  • Finlay JL, Boyett JM, Yates AJ, et al. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. J Clin Oncol. 1995;13: 112-123.[Abstract/Free Full Text]
  • MacDonald TJ, Arenson E., Sposto R., et al. Phase II study of high dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group study 9933. Cancer. 2005;104: 2862-2871.[Medline] [Order article via Infotrieve]
  • Rubin G., Michowitz S., Horev G., et al. Pediatric brain stem gliomas: an update. Childs Nerv Syst. 1998;14:167-173.[CrossRef][Medline] [Order article via Infotrieve]
  • Mandell LR, Kadota R., Freeman C., et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys. 1999;43:959-964.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Farmer JP, Montes JL, Freeman CR, et al. Brainstem Gliomas. A 10-year institutional review. Pediatr Neurosurg. 2001;34: 206-214.[CrossRef][Medline] [Order article via Infotrieve]
  • Horn B., Heideman R., Geyer R., et al. A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. J Pediatr Hematol Oncol. 1999;21:203-211.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Merchant TE, Jenkins JJ, Burger PC, et al. Influence of tumor grade on time to progression after irradiation for localized ependymoma in children. Int J Radiat Oncol Biol Phys. 2002;53:52-57.[Web of Science][Medline] [Order article via Infotrieve]
  • Bouffet E., Perilongo G., Canete A., et al. Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol. 1998;30:319-329.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Journal of Child Neurology, Vol. 23, No. 10, 1122-1127 (2008)
DOI: 10.1177/0883073808320758
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J Child NeurolHome page
R. A. Brumback
Child Neurologists Should Be Interested In Brain Tumors!
J Child Neurol, November 1, 2009; 24(11): 1338 - 1340.
[PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Packer, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Packer, R. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?